Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017–2023

Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017–2023

Saved in:

Bibliographic Details
Main Authors:	Donghee Kim, Rohit Loomba, Aijaz Ahmed
Format:	Article
Language:	English
Published:	Korean Association for the Study of the Liver 2025-07-01
Series:	Clinical and Molecular Hepatology
Subjects:	nafld sld nhanes prevalence
Online Access:	http://e-cmh.org/upload/pdf/cmh-2024-1150.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The burden of steatotic liver disease before and during the COVID-19 pandemic: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”
by: Donghee Kim, et al.
Published: (2025-04-01)

Addressing the burden of steatotic liver disease: The role of transient elastography: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”
by: Donghee Kim, et al.
Published: (2025-04-01)

BMI gain and dietary characteristics are risk factors of MASLD in non-obese individuals
by: Hirokazu Taniguchi, et al.
Published: (2025-01-01)

Differences in the incidence of cirrhosis-associated complications between MASLD, MetALD and ALD among patients with decompensated liver cirrhosis
by: Laura Buttler, et al.
Published: (2025-01-01)

Differences in the incidence of cirrhosis-associated complications between MASLD, MetALD and ALD among patients with decompensated liver cirrhosis.
by: Laura Buttler, et al.
Published: (2025-01-01)

Clinical characteristics of MASLD/MetALD/MAFLD/NAFLD and the relative risk analysis on metabolic disorders
by: Hong-ye Peng, et al.
Published: (2025-05-01)

MetALD: Clinical aspects, pathophysiology and treatmentKeypoints
by: Jordi Gratacós-Ginès, et al.
Published: (2025-02-01)

Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023
by: Donghee Kim, et al.
Published: (2025-04-01)

Comprehensive analysis of peripheral blood free amino acids in MASLD: the impact of glycine-serine-threonine metabolism
by: Masaaki Mino, et al.
Published: (2024-12-01)

DHCR7 inhibition ameliorates MetALD and HCC in mice and human 3D liver spheroids
by: Gen Yamamoto, et al.
Published: (2025-07-01)

High-Sensitivity C-Reactive Protein Levels in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Alcohol-Associated Liver Disease (MetALD), and Alcoholic Liver Disease (ALD) with Metabolic Dysfunction
by: Seong-Uk Baek, et al.
Published: (2024-11-01)

Association of blood manganese levels with non-alcoholic fatty liver disease in NHANES 2017–2020: A retrospective cross-sectional study
by: Qian Xue, et al.
Published: (2025-06-01)

P-12 METHYL GROUP DONOR SUPPLEMENTATION IN A MetALD MODEL: REGULATION OF GUT MICROBIOTA AND METABOLIC PARAMETERS
by: Carolina Díaz Canul, et al.
Published: (2024-12-01)

The association between the dietary index for gut microbiota and non-alcoholic fatty liver disease and liver fibrosis: evidence from NHANES 2017–2020
by: Ce Zheng, et al.
Published: (2025-03-01)

Association of hepatic steatosis and liver fibrosis with chronic obstructive pulmonary disease among adults
by: Dayang Zheng, et al.
Published: (2024-05-01)

Machine learning models integrating dietary data predict all-cause mortality in U.S. NAFLD patients: an NHANES-based study
by: Pinchu Chen, et al.
Published: (2025-07-01)

Association between the NHHR and hepatic steatosis and liver fibrosis: a population-based study
by: Xiaoxian Yang, et al.
Published: (2025-03-01)

Fucoidan from Fucus vesiculosus alleviates MetALD via promoting HIF-1α ubiquitination to suppress peripheral monocyte infiltration
by: Lei Li, et al.
Published: (2025-08-01)

Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis
by: Arantza Lamas-Paz, et al.
Published: (2025-01-01)

The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a predictive indicator of CKD risk in NAFLD patients: NHANES 2017–2020
by: Yong-Qiang Fan, et al.
Published: (2024-12-01)

Cognitive profiles in bilingual children born to immigrant parents and Italian monolingual native children with specific learning disorders
by: Riva A, et al.
Published: (2016-12-01)

AISI and MASLD: a nonlinear association in U.S. adults (NHANES 2017-2020)
by: Xue Xiao, et al.
Published: (2025-08-01)

New steatotic liver disease criteria diagnostic performance in an agricultural population in Chile
by: Maria Spencer-Sandino, et al.
Published: (2025-07-01)

Optimization of the Proportion of Surfactant, Co-Surfactant, and Candlenut Oil for Self-Nanoemulsifying Drug Delivery System (SNEDDS) of Secang Heartwood (Caesalpinia sappan L.) Methanolic Extract
by: Anif Nur Artanti, et al.
Published: (2021-03-01)

Association of serum lactate dehydrogenase levels with non-alcoholic fatty liver disease and advanced hepatic fibrosis in the United States: a cross-sectional study using NHANES data from 2007 to 2018
by: Xiaotong Zhang, et al.
Published: (2025-07-01)

The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a predictor of all cause and cardiovascular mortality in United States adults with NAFLD: a prospective cohort study
by: Lisha Yang, et al.
Published: (2025-04-01)

Association of alpha-1 acid glycoprotein with hepatic steatosis and liver fibrosis among women: a population-based study
by: Sichang Wang
Published: (2025-08-01)

Utility of the serum alanine aminotransferase to high density lipoprotein cholesterol ratio in evaluating nonalcoholic fatty liver disease and liver fibrosis
by: Yanyan Xuan, et al.
Published: (2025-07-01)

Current virtual reality-based rehabilitation interventions in neuro-developmental disorders at developmental ages
by: Micaela Capobianco, et al.
Published: (2025-01-01)

Research progress on AMPK in the pathogenesis and treatment of MASLD
by: Jiang Feng, et al.
Published: (2025-03-01)

From MASLD to PAD: Looking for Cardiovascular Disease Starting from Metabolic Status
by: Andrea Boccatonda, et al.
Published: (2024-10-01)

Mitochondrial dysfunction characterises the multigenerational effects of maternal obesity on MASLD
by: Anneleen Heldens, et al.
Published: (2025-06-01)

Development of a novel deep learning method that transforms tabular input variables into images for the prediction of SLD
by: Gabriel Cubillos, et al.
Published: (2025-07-01)

Study of Prevalence of Non-Alcoholic Fatty Liver Disease in Hypothyroidism and Possible Association of Hypothyroidism with NAFLD Fibrosis Score in Odisha
by: Siba Prasad Dalai, et al.
Published: (2024-07-01)

METS-VF as a novel predictor of gallstones in U.S. adults: a cross-sectional analysis (NHANES 2017–2020)
by: Hui Wang, et al.
Published: (2025-07-01)

Association Between High Sensitivity Cardiac Troponin and All-Cause and Cardiovascular Mortality in Adults at Risk of Non-Alcoholic Fatty Liver Disease: A Cohort Study
by: Enfa Zhao, et al.
Published: (2025-04-01)

Meta-analysis of shotgun sequencing of gut microbiota in obese children with MASLD or MASH
by: Thomas Zöggeler, et al.
Published: (2025-12-01)

A murine model of gestational diabetes reveals MASLD risk and alterations in markers of hepatic mitochondrial metabolism
by: Grace E. Shryack, et al.
Published: (2025-06-01)

Plasma Circulating Metabolites Associated With Steatotic Liver Disease and Liver Enzymes: A Multiplatform Population-Based Study
by: Yasir J. Abozaid, et al.
Published: (2025-01-01)

Association between eGDR and MASLD and liver fibrosis: a cross-sectional study based on NHANES 2017–2023
by: Wenjing Peng, et al.
Published: (2025-05-01)